D. E. Shaw & Co., Inc.’s Abbott Laboratories Position
Does D. E. Shaw & Co., Inc. own Abbott Laboratories (ABT)? Yes — 5.28M shares worth $542M (+0.33% of its 13F portfolio) as of Q1 2026, up from 1.35M shares the prior filed quarter.
Position Value
$542M
Q1 2026
Shares
5.28M
% of Portfolio
+0.33%
Quarters Held
27
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.28M | $542M | +0.33% |
| Q4 2025 | 1.35M | $170M | +0.09% |
| Q3 2025 | 39.8K | $5M | 0.00% |
| Q2 2025 | 6.3K | $854,007 | 0.00% |
| Q1 2025 | 17.1K | $2M | 0.00% |
| Q4 2024 | 29.1K | $3M | 0.00% |
| Q3 2024 | 96.5K | $11M | +0.01% |
| Q2 2024 | 1.02M | $106M | +0.10% |
| Q1 2024 | 50.9K | $6M | 0.00% |
| Q4 2023 | 9.9K | $1M | 0.00% |
| Q3 2023 | 140.7K | $14M | +0.01% |
| Q2 2023 | 469.1K | $51M | +0.05% |
| Q1 2023 | 778.8K | $79M | +0.08% |
| Q4 2022 | 455.3K | $50M | +0.06% |
| Q3 2022 | 1.28M | $124M | +0.15% |
| Q2 2022 | 1.63M | $177M | +0.21% |
| Q1 2022 | 2.35M | $279M | +0.26% |
| Q4 2021 | 596.7K | $84M | +0.07% |
| Q3 2021 | 704.1K | $83M | +0.08% |
| Q2 2021 | 2.19M | $254M | +0.22% |
| Q1 2021 | 1.73M | $207M | +0.20% |
| Q4 2020 | 1.56M | $171M | +0.15% |
| Q3 2020 | 906.8K | $99M | +0.10% |
| Q2 2020 | 8.6K | $786,000 | 0.00% |
| Q1 2020 | 12.3K | $971,000 | 0.00% |
| Q4 2019 | 2.4K | $212,000 | 0.00% |
| Q3 2019 | 8.8K | $736,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of ABT.